Podcast: Celltrion’s Subcutaneous Infliximab And The Future Of Biosimilars

We Discuss The Celltrion Product Breaking New Ground For Biosimilars

 
• By David Wallace
  
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products